Skip to main content

Table 2 Baseline levels of cardiometabolic markers according to serum 25(OH)D concentrations among participants with OA

From: L-shaped association of serum 25-hydroxyvitamin D concentrations with cardiovascular and all-cause mortality in individuals with osteoarthritis: results from the NHANES database prospective cohort study

  Serum 25(OH)D concentrations (nmol/L) P-value
< 25.00 25.00–49.99 50.00–74.99 ≥ 75.00
Glycohemoglobin (%) 6.11 ± 1.00 6.01 ± 1.17 5.81 ± 0.88 5.76 ± 0.72 <0.01
Glucose, refrigerated serum (mg/dL) 107.38 ± 37.24 111.62 ± 48.65 103.66 ± 33.25 102.25 ± 28.10 <0.01
Cholesterol (mg/dL) 199.24 ± 39.41 201.03 ± 45.62 199.61 ± 42.95 201.46 ± 42.75 0.76
Direct HDL-cholesterol (mg/dL) 54.96 ± 14.38 53.02 ± 16.13 53.15 ± 15.54 57.15 ± 16.90 <0.01
LDL-cholesterol (mg/dL) 111.00 ± 32.59 117.08 ± 37.38 116.48 ± 36.58 114.50 ± 36.59 0.48
Triglycerides (mg/dL) 153.18 ± 98.98 159.22 ± 117.47 159.46 ± 110.97 159.37 ± 108.93 0.81
eGFR (mL/min/1.73 m2) 81.14 ± 27.80 80.81 ± 25.29 77.11 ± 20.91 73.37 ± 20.86 <0.01
Uric acid (mg/dL) 6.15 ± 1.70 5.64 ± 1.45 5.58 ± 1.47 5.48 ± 1.45 <0.01
C-reactive protein (mg/dL) 0.84 ± 1.39 0.55 ± 0.66 0.50 ± 0.80 0.49 ± 0.96 <0.01
  1. Mean ± SD for continuous variables: P-value was calculated by weighted linear regression model